Cost- Effectiveness of a Face-to-Face Rehabilitation Program vs an Telemedicine Program in Chronic Low Back Pain
CompletedNot applicableNCT04266366
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Perform a cost-utility analysis in patients with chronic low back pain through electroanalgesia treatment and exercises administered by telemedicine program versus face-to-face program
Study details
- Official title
- Comparison of Cost and Cost- Effectiveness of a Face-to-Face Rehabilitation Program vs an Telemedicine Program on Disability, Pain, Fear of Movement, Quality of Life and Spinal Mobility in Patients With Chronic Low Back Pain
- Conditions
- Interventions
- Other: Face-to-Face Rehabilitation program
- Other: Telemedicine program
- Sponsor
- Universidad de Almeria
- Collaborators
- Junta de Andalucia
- Start date
- 2020-03-01
- Primary completion
- 2022-03-01
- Sex
- All
- Age range
- from 30 Years to 67 Years
- Results posted
- No results posted in this snapshot
- Countries
- Spain
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Low back pain ≥ 3 months. * Age between 30 and 67 years old. * Not being receiving physical therapy. Exclusion Criteria: * Presence of lumbar stenosis. * Diagnosis of spondylolisthesis. * Diagnosis of fibromyalgia. * Treatment with corticosteroids or oral medication in recent weeks. * History of spine surgery. * Contraindication of analgesic electrical therapy. * Have previously received a treatment of electrical analgesia or exercise. * Central or peripheral nervous system disease.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04266366